Gene Editing for <i>CEP290</i> -Associated Retinal Degeneration
#3PRI RANKED
Most Cited Paper
in Retinal Diseases and Treatments
18 Months Post-Publication
Class of 2026
“Gene Editing for <i>CEP290</i> -Associated Retinal Degeneration”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026/
Topics
EDIT-101 · CEP290 IVS26 variant · CRISPR-Cas9 gene editing · in vivo gene editing · Subretinal injection · Leber congenital amaurosis · Inherited retinal degeneration · full-field stimulus testing · Best-corrected visual acuity (BCVA) · Ora-Visual Navigation Challenge mobility test · National Eye Institute Visual Function Questionnaire-25 · Children's Visual Function Questionnaire · Photoreceptors · dose-limiting toxicity assessment · photoreceptor gene therapy · BRILLIANCE clinical trial
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Diseases and Treatments Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459